Literature DB >> 10718968

Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy

.   

Abstract

Aims: Despite increasingly radical surgery for oesophageal cancer many patients continue to represent with recurrent disease. This study aimed to evaluate the pattern of failure following attempted curative oesophagectomy with mediastinal and upper abdominal lymphadenectomy.
METHODS: Some 212 consecutive patients undergoing R0 resection for malignancy between 1 April 1990 and 1 April 1999 were followed up for evidence of recurrence. Clinical evaluation was supported by ultrasonography, computed tomography, isotope scan, endoscopy and laparotomy with biopsy assessment if appropriate. Patients were excluded if recurrence was diagnosed on clinical grounds alone. Statistical analysis was performed using chi2 and log rank tests.
RESULTS: Some 142 patients with adenocarcinoma and 70 with squamous carcinoma (SCC) were followed up for a median of 14 (range 1-108) months. Sex and age distribution were similar for both histological subtypes (men : women 3 : 1; median age 64 (30-79) years). Twenty patients died from non-cancer related causes, including 11 (5 per cent) from postoperative complications. Some 89 patients (42 per cent) developed proven recurrent disease of which seven are alive and 82 dead. The median time to recurrence was 11 (2-40) months with a median time to death thereafter of 3 (1-21) months. The pattern of recurrence was locoregional in 23 per cent (oesophageal bed 15 per cent, upper abdominal 3 per cent, upper mediastinal 3 per cent, cervical 2 per cent) and haematogenous in 18 per cent (comprising liver 8 per cent, bone 4 per cent, cerebral 3 per cent, lung 2 per cent, skin 1 per cent) with peritoneal dissemination in 1 per cent. While there was no difference in the overall pattern of dissemination for each histological subtype, the incidence of cervical and upper mediastinal recurrence was significantly higher for adenocarcinoma compared with SCC (chi2 = 5. 9, 1 d.f., P < 0.02). The timing of recurrence was similar for both histological subtypes: 60 per cent of all recurrence occurred within 12 months of surgery, with distant and locoregional recurrence occurring at a median of 10 (2-40) and 11 (2-32) months respectively.
CONCLUSIONS: The low incidence of upper mediastinal and cervical recurrence suggests that more extensive lymphadenectomy is unlikely to impact upon survival. Improved staging modalities are required to identify the significant number of patients who develop early recurrence in the first year following surgery in order to offer them multimodality therapies of non-surgical palliation.

Entities:  

Year:  2000        PMID: 10718968     DOI: 10.1046/j.1365-2168.2000.01383-5.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

1.  The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer.

Authors:  Simon Law; Dora L W Kwong; Kam-Ho Wong; Ka-Fai Kwok; John Wong
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

Review 2.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

3.  18FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma.

Authors:  Sonia L Betancourt Cuellar; Diana P Palacio; Carol C Wu; Brett W Carter; Arlene M Correa; Wayne L Hofstetter; Edith M Marom
Journal:  Br J Radiol       Date:  2017-11-28       Impact factor: 3.039

Review 4.  Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis.

Authors:  Guo-Wei Ma; Dong-Rong Situ; Qi-Long Ma; Hao Long; Lan-Jun Zhang; Peng Lin; Tie-Hua Rong
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

6.  Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease.

Authors:  Daniel King-Hung Tong; Dora Lai Wan Kwong; Simon Law; Kam Ho Wong; John Wong
Journal:  J Gastrointest Surg       Date:  2008-08-14       Impact factor: 3.452

7.  Impact of solitary involved lymph node on outcome in localized cancer of the esophagus and esophagogastric junction.

Authors:  James M O'Riordan; Suzanne Rowley; James O Murphy; Narayasami Ravi; Patrick J Byrne; John V Reynolds
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

8.  Is there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma.

Authors:  Shau-Hsuan Li; Yung-Cheng Huang; Wan-Ting Huang; Wei-Che Lin; Chien-Ting Liu; Wan-Yu Tien; Hung-I Lu
Journal:  BMC Cancer       Date:  2012-08-01       Impact factor: 4.430

9.  Recurrence risk after Ivor Lewis oesophagectomy for cancer.

Authors:  Mael Chalret du Rieu; Thomas Filleron; Benoit Beluchon; Marine Humeau; Charles-Henri Julio; Eric Bloom; Laurent Ghouti; Sylvain Kirzin; Guillaume Portier; Bernard Pradère; Nicolas Carrère
Journal:  J Cardiothorac Surg       Date:  2013-11-21       Impact factor: 1.637

10.  Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma.

Authors:  Wen-Lun Wang; Wei-Lun Chang; Hsiao-Bai Yang; Yu-Chi Wang; I-Wei Chang; Ching-Tai Lee; Chi-Yang Chang; Jaw-Town Lin; Bor-Shyang Sheu
Journal:  Oncotarget       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.